152 related articles for article (PubMed ID: 25383675)
1. Post-transcriptional up-regulation of PDGF-C by HuR in advanced and stressed breast cancer.
Luo NA; Qu YQ; Yang GD; Wang T; Li RL; Jia LT; Dong R
Int J Mol Sci; 2014 Nov; 15(11):20306-20. PubMed ID: 25383675
[TBL] [Abstract][Full Text] [Related]
2. mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells.
Bolognani F; Gallani AI; Sokol L; Baskin DS; Meisner-Kober N
J Neurooncol; 2012 Feb; 106(3):531-42. PubMed ID: 21935689
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
[TBL] [Abstract][Full Text] [Related]
4. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.
Guo X; Hartley RS
Cancer Res; 2006 Aug; 66(16):7948-56. PubMed ID: 16912169
[TBL] [Abstract][Full Text] [Related]
5. Caspase-mediated cleavage of RNA-binding protein HuR regulates c-Myc protein expression after hypoxic stress.
Talwar S; Jin J; Carroll B; Liu A; Gillespie MB; Palanisamy V
J Biol Chem; 2011 Sep; 286(37):32333-43. PubMed ID: 21795698
[TBL] [Abstract][Full Text] [Related]
6. Destabilization of ERBB2 transcripts by targeting 3' untranslated region messenger RNA associated HuR and histone deacetylase-6.
Scott GK; Marx C; Berger CE; Saunders LR; Verdin E; Schäfer S; Jung M; Benz CC
Mol Cancer Res; 2008 Jul; 6(7):1250-8. PubMed ID: 18644987
[TBL] [Abstract][Full Text] [Related]
7. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
Nabors LB; Gillespie GY; Harkins L; King PH
Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
[TBL] [Abstract][Full Text] [Related]
8. Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells.
Leandersson K; Riesbeck K; Andersson T
Nucleic Acids Res; 2006; 34(14):3988-99. PubMed ID: 16914445
[TBL] [Abstract][Full Text] [Related]
9. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer.
Al-Ahmadi W; Al-Ghamdi M; Al-Souhibani N; Khabar KS
J Pathol; 2013 May; 230(1):28-38. PubMed ID: 23401122
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent.
Chu PC; Kulp SK; Chen CS
Carcinogenesis; 2013 Dec; 34(12):2694-705. PubMed ID: 23864387
[TBL] [Abstract][Full Text] [Related]
11. Regulation of non-AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer.
Woo HH; Zhou Y; Yi X; David CL; Zheng W; Gilmore-Hebert M; Kluger HM; Ulukus EC; Baker T; Stoffer JB; Chambers SK
Oncogene; 2009 Mar; 28(9):1176-86. PubMed ID: 19151756
[TBL] [Abstract][Full Text] [Related]
12. IL-1beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3' untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR.
Suswam EA; Nabors LB; Huang Y; Yang X; King PH
Int J Cancer; 2005 Mar; 113(6):911-9. PubMed ID: 15514971
[TBL] [Abstract][Full Text] [Related]
13. The RNA-binding protein HuR regulates GATA3 mRNA stability in human breast cancer cell lines.
Licata LA; Hostetter CL; Crismale J; Sheth A; Keen JC
Breast Cancer Res Treat; 2010 Jul; 122(1):55-63. PubMed ID: 19728080
[TBL] [Abstract][Full Text] [Related]
14. The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence.
Jansson S; Aaltonen K; Bendahl PO; Falck AK; Karlsson M; Pietras K; Rydén L
Breast Cancer Res Treat; 2018 Jun; 169(2):231-241. PubMed ID: 29380207
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR.
Nabors LB; Suswam E; Huang Y; Yang X; Johnson MJ; King PH
Cancer Res; 2003 Jul; 63(14):4181-7. PubMed ID: 12874024
[TBL] [Abstract][Full Text] [Related]
16. The interplay of HuR and miR-3134 in regulation of AU rich transcriptome.
Sharma S; Verma S; Vasudevan M; Samanta S; Thakur JK; Kulshreshtha R
RNA Biol; 2013 Aug; 10(8):1283-90. PubMed ID: 23823647
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells.
Devarajan E; Song YH; Krishnappa S; Alt E
Int J Cancer; 2012 Sep; 131(5):1023-31. PubMed ID: 22038895
[TBL] [Abstract][Full Text] [Related]
18. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma.
Denkert C; Weichert W; Winzer KJ; Müller BM; Noske A; Niesporek S; Kristiansen G; Guski H; Dietel M; Hauptmann S
Clin Cancer Res; 2004 Aug; 10(16):5580-6. PubMed ID: 15328200
[TBL] [Abstract][Full Text] [Related]
19. Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells.
Sharma A; Bhat AA; Krishnan M; Singh AB; Dhawan P
Carcinogenesis; 2013 Nov; 34(11):2610-21. PubMed ID: 23880304
[TBL] [Abstract][Full Text] [Related]
20. Antagonizing effect of CLPABP on the function of HuR as a regulator of ARE-containing leptin mRNA stability and the effect of its depletion on obesity in old male mouse.
Nishino T; Matsunaga R; Jikihara H; Uchida M; Maeda A; Qi G; Abe T; Kiyonari H; Tashiro S; Inagaki-Ohara K; Shimamoto F; Konishi H
Biochim Biophys Acta; 2016 Nov; 1861(11):1816-1827. PubMed ID: 27616329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
